See What HealthDay Can Do For You
Contact Us

Opioid Prescriptions Common With Fibromyalgia

Patients taking opioids are less likely to subsequently receive guideline-recommended therapy

woman in pain

TUESDAY, Oct. 20, 2015 (HealthDay News) -- Opioid use is widespread among patients with newly diagnosed fibromyalgia, and patients taking opioids have a decreased likelihood of receiving guideline-recommended medications, according to a study published online Oct. 7 in Pain Practice.

Rachel Halpern, Ph.D., M.P.H., from Optum in Eden Prairie, Minnesota, and colleagues conducted a retrospective claims data analysis of adult commercial health plan members newly diagnosed with fibromyalgia (initial diagnosis = index date) from January 2008 to February 2012. Patients received pain medication within six months post-index.

The researchers found that the 96,175 patients (mean age, 47.3 years; 72.5 percent female) were prescribed medications in the following proportions: short-acting opioid (SAO), 57 percent; selective serotonin reuptake inhibitor (SSRI), 22 percent; anti-epileptic drug (AED), 10 percent ; serotonin-norepinephrine reuptake inhibitor (SNRI), 6 percent; tricyclic antidepressant (TCA), 3 percent; and long-acting opioid (LAO), 2 percent. The most discontinuation and the least augmentation were seen in the SAO cohort. Patients with pre-index guideline-recommended medications were two to four times more likely to receive them post-index compared with those without pre-index recommended medications. Patients in the opioid cohorts were approximately half as likely to then receive guideline-recommended medications.

"These real-world results indicate an opportunity may exist for improved FM management using recommended therapies in clinical practice," conclude the authors.

The study was supported by Pfizer; several authors disclosed financial ties to the company.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.